USPTO serial 97671635
MICRO3PL
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- RINGLE, JAMES W
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MICRO3PL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Marjorie Witter Norman
Marjorie Witter Norman REED SMITH LLPP.O. BOX 488PITTSBURGH, PA 15230United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for centralized ordering, dispensing, fulfillment, shipping, tracking, transportation, delivery, and storage of vaccines, pharmaceuticals, biological tissues and substances, medical devices, and medical products for human medical use | ACTIVE | — |
| 035 | Distributorship services in the field of vaccines, pharmaceuticals, biological tissues and substances, medical devices, and medical products for human medical use; distribution logistics, namely, tracking the ordering, dispensing, fulfillment, shipping, and delivery of vaccines, pharmaceuticals, biological tissues and substances, medical devices, and medical products for human medical use; distribution logistics, namely, tracking the ordering, dispensing, fulfillment, shipping, and delivery of vaccines, pharmaceuticals, biological tissues and substances, medical devices, and medical products for human medical use over a global computer network; arranging for pick-up, dispensing, fulfillment, shipping, tracking, transportation, delivery, and storage of vaccines, pharmaceuticals, biological tissues and substances, medical devices, and medical products for human medical use by land and air; providing electronic tracking of pick-up, dispensing, fulfillment, shipping, tracking, transportation, delivery, and storage of vaccines, pharmaceuticals, biological tissues and substances, medical devices, and medical products for human medical use by land and air, all for business purposes; providing tracking services and information concerning tracking of assets in transit, namely, tracking of pick-up, transport, delivery, and storage of vaccines, pharmaceuticals, biological tissues and substances, medical devices, and medical products for human medical use for business inventory purposes; providing a website featuring tracking information regarding the fulfillment, shipping, transportation, and storage of vaccines, pharmaceuticals, biological tissues and substances, medical devices, and medical products for human medical use for business inventory purposes; online centralized ordering and order-fulfillment services featuring vaccines, pharmaceuticals, biological tissues and substances, medical devices, and medical products for human medical use | ACTIVE | — |
| 039 | Shipping and delivery services, namely, pick-up, transportation, delivery, and storage of vaccines, pharmaceuticals, biological tissues and substances, medical devices, and medical products for human medical use; transportation of vaccines, pharmaceuticals, biological tissues and substances, medical devices, and medical products for human medical use via land and air, namely, by courier, cars, vans, trucks, trains and airplanes; physical storage services featuring vaccines, pharmaceuticals, biological tissues and substances, medical devices, and medical products for human medical use | ACTIVE | — |
| 042 | Software as a service (SAAS) services provided via a global computer network featuring software for use in centralized ordering, dispensing, fulfillment, shipping, tracking, transportation, delivery, and storage of vaccines, pharmaceuticals, biological tissues and substances, medical devices, and medical products for human medical use | ACTIVE | — |
| 044 | Online dispensing of pharmaceuticals, biological substances, vaccines, biopharmaceuticals, human blood products, plasma products, and biological tissues | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by FFF Enterprises, Inc.
- Other trademarks owned by FFF Enterprises, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 039
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MICRO3PL
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 27, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 27, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 22, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 22, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 21, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 21, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 24, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 30, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 30, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 10, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 24, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 18, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 18, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 18, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Mar 27, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Mar 27, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 27, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 28, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 28, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 28, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 25, 2023 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Oct 25, 2023 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Aug 28, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 28, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 28, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 24, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 17, 2023 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Aug 17, 2023 | ALIE | ASSIGNED TO LIE | — |
| Apr 5, 2023 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Nov 30, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 14, 2022 | NWAP | NEW APPLICATION ENTERED | — |